FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

By AHJ Staff June 17, 2020

The U.S. Food and Drug Administration recently rescinded its emergency use authorization for hydroxychloroquine to treat COVID-19. Based on new evidence, the agency said that the potential benefits of taking hydroxychloroquine and chloroquine to treat COVID-19 did not outweigh the risks (The New York Times).

AHJ Staff

American Healthcare Journal is healthcare’s No. 1 source for the latest insights, news and analysis. An authoritative, digital-first and editorially independent publication committed to providing decision makers with unparalleled thought leadership and objective, industry-focused information to help them run their businesses in the new era of healthcare.

Newsletter
Enter your email address to
subscribe to our newsletter.

Thank you for Signing Up
Please correct the marked field(s) below.
1,true,6,Subscriber Email,2
1,false,1,First Name,2
COVID-19 Resource Center ›
Featured Articles

July 9, 2021
Sen. Feinstein: Congress Must Address The Youth Vaping Crisis

Even before COVID-19 ravaged our country, e-cigarettes posed a serious health threat to America’s youth. As we emerge from the COVID-19 pandemic, the youth vaping crisis remains an urgency that Congress must address.

Read More

June 16, 2021
Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

Majority of remaining practices uncertain when pre-COVID levels will resume

Read More

February 26, 2021
To Create ‘Just’ Medicine, What Is In Your Lane?

The COVID-19 pandemic, if nothing else, has aimed a harsh light at our healthcare systems, illuminating the type of public health system we all need to better prepare for the next pandemic. To a person, it behooves us to work on changing these uncovered and pressing issues that COVID-19 has now exposed, so that we can be stronger as we move forward into a post-pandemic society. But what is in our lane of responsibility and what is not?

Read More

FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

Featured Articles

Sen. Feinstein: Congress Must Address The Youth Vaping Crisis

Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

To Create ‘Just’ Medicine, What Is In Your Lane?

Featured Articles

Survey: More Than 70 Percent of Medical Practices Expect Their Patient Volume in 2021 to be Higher Than 2020

To Create ‘Just’ Medicine, What Is In Your Lane?

Who Should Be Next?

Student Loan Forgiveness For Frontline Professionals: Fortifying Future Supply

FDA pulls emergency use authorization of hydroxychloroquine for COVID-19

Related Posts